Who is sponsoring NCT03363308?

NCT03363308 is sponsored by Jhpiego.

What drugs are being tested in NCT03363308?

Interventions in NCT03363308: training for health care workers supplmented by QI teams.

What condition does NCT03363308 study?

NCT03363308 studies Maternal Death, Infant Death, Stillbirth.

Is NCT03363308 still recruiting?

NCT03363308 is currently completed. Last updated 24 July 2020.

Last reviewed 2020-07-24 · How we verify

NCT03363308

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of a Health Workforce Capacity Building and Quality Improvement Intervention in Kinshasa

Completed NA Last updated 24 July 2020

What this trial tests

NA trial testing training for health care workers supplmented by QI teams in Maternal Death in 250 participants. Completed in 30 June 2020.

Timeline

16 November 2017

Primary endpoint
30 June 2020

30 June 2020

Quick facts

Lead sponsor	Jhpiego
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	250
Start date	16 November 2017
Primary completion	30 June 2020
Estimated completion	30 June 2020
Sites	1 location across Democratic Republic of the Congo

Drugs / interventions tested

training for health care workers supplmented by QI teams

Conditions studied

Maternal Death — all drugs for Maternal Death →
Infant Death — all drugs for Infant Death →
Stillbirth — all drugs for Stillbirth →

Sponsor

Jhpiego — full company profile →

Who can join

18 and older, any sex, with Maternal Death or Infant Death. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate a health workforce capacity building and quality improvement intervention focused on integrated day-of-birth and post-pregnancy care at 16 hospitals in Kinshasa, Democratic Republic of Congo. The intervention package consists of a low-dose, high-frequency (LDHF) training of health workers, support for quality improvement teams, and provision of critical equipment, supplies and drugs within a quality improvement (QI) framework.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effectiveness of Capacity-Building and Quality Improvement Interventions to Improve Day-of-Birth Care in Kinshasa, Democratic Republic of the Congo.
Kikaya V, Katembwe F, Yabili J, Mbwanya M, et al · · 2024 · cited 2× · PMID 38365280 · DOI 10.9745/ghsp-d-23-00236

Verify or expand the search:

Other recruiting trials for Maternal Death

Currently open trials in the same condition.

NCT07187596 — Mortality Outcome of Controlled Hypertension · active not recruiting
NCT06415942 — Assessing the Maternal Outcome Monitoring Systems · NA · recruiting
NCT05382403 — Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage · NA · recruiting
NCT06273007 — Improving Intrapartum Care for Saving Life at Birth in Ethiopia Through PartoMa Approach · NA · recruiting

Other Jhpiego trials

Trials by the same sponsor.

NCT06258200 — The Role of Gender Transformative Interventions to Strengthen Gender Equity and Improve Immunization Outcomes · NA · active not recruiting
NCT05774626 — Injectable Contraception Cohort Study in Punjab, Pakistan · completed
NCT05563974 — Family Led Postnatal Care in Ethiopia · NA · completed
NCT05565196 — Birth Companion Intervention in Ethiopia, Kenya and Nigeria · NA · completed
NCT05133661 — SUCCESS - Feasibility of HPV Testing and Treatment of Pre-cancerous Cervical Cancer Lesions (HPV Study) · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03363308 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jhpiego
Last refreshed: 24 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03363308.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing